STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G] Alpha Cognition Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary

Alpha Cognition Inc. received a Schedule 13G reporting that Opaleye Management Inc., Opaleye, L.P. and James Silverman together beneficially own 1,875,142 shares of Alpha Cognition common stock, representing 8.97% of the class based on 20,902,104 shares outstanding as cited. The filing shows no sole voting or dispositive power; instead the holders report shared voting and shared dispositive power over the reported shares. The statement clarifies the Adviser–Fund relationship and that Mr. Silverman exercises control over the Adviser, and includes a certification that the stake was not acquired to change control. Signatures are dated 10/03/2025 and the issuer address is listed in Grapevine, Texas.

Positive
  • Transparency: Public disclosure of 1,875,142 shares ( 8.97% ) provides clear ownership information
  • Certification: Filing includes a certification that the stake was not acquired to change control
Negative
  • No sole voting or dispositive power: Holders report 0 shares of sole voting or dispositive authority
  • Concentrated ownership: A near-9% stake is material and could attract attention from other shareholders or activists

Insights

Opaleye discloses a 8.97% passive stake in Alpha Cognition.

The filing reports an aggregate holding of 1,875,142 shares held with shared voting and shared dispositive power, indicating coordinated ownership rather than sole control. This level of ownership is materially above 5% and therefore requires public disclosure under Schedule 13G rules.

Because the filing includes a certification that the position is not intended to influence control, the stake appears to be reported as passive for regulatory purposes.

Shared voting power and adviser structure limit unilateral control.

The report names Opaleye Management Inc. as adviser to Opaleye, L.P. with James Silverman exercising control over the adviser, yet all voting and dispositive powers are reported as shared, not sole. That structure signals coordinated decision-making rather than an individual controller.

The filing’s certification that the holdings were not acquired to change control reduces immediate governance-impact concerns disclosed in this statement.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G




Comment for Type of Reporting Person: Based on 20,902,104 Common Shares outstanding as reported by Alpha Cognition, Inc. in its Form 424B5 filed with the SEC on October 1, 2025.


SCHEDULE 13G





SCHEDULE 13G



Opaleye Management Inc.
Signature:/s/ James Silverman
Name/Title:President
Date:10/03/2025
Opaleye, L.P.
Signature:/s/ James Silverman
Name/Title:General Partner
Date:10/03/2025
James Silverman
Signature:/s/ James Silverman
Name/Title:Individually
Date:10/03/2025
Exhibit Information

Exhibit 99.1 Joint Filing Agreement by and among the reporting persons

FAQ

What stake did Opaleye report in Alpha Cognition (ACOG)?

Opaleye reported beneficial ownership of 1,875,142 shares, equal to 8.97% of the common stock.

Does Opaleye have sole voting control over the reported shares?

No. The filing reports 0 shares of sole voting power and 1,875,142 shares of shared voting power.

On what outstanding share count is the 8.97% calculated?

The percentage is based on 20,902,104 common shares outstanding as reported in Alpha Cognition’s Form 424B5 filed October 1, 2025.

Who signed the Schedule 13G for Opaleye and when?

The filing is signed by James Silverman in his roles for Opaleye Management Inc., Opaleye, L.P., and individually, dated 10/03/2025.

Did the filing state an intent to change or influence control of Alpha Cognition?

No. The certification states the securities were not acquired and are not held to change or influence control.
Alpha Cognition

NASDAQ:ACOG

ACOG Rankings

ACOG Latest News

ACOG Latest SEC Filings

ACOG Stock Data

128.71M
19.65M
12.97%
35.39%
0.5%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
Canada
VANCOUVER